Q2 Results: Nava Profit Surges 144%, Taj GVK Slips on Margin Dip

Quarterly corporate earnings continued to drive sharp stock-specific action on Dalal Street on Thursday, November 12, 2026, as three prominent mid-cap and small-cap companies—Nava Limited, Taj GVK Hotels & Resorts, and Caplin Point Laboratories—unveiled their financial scorecards for the second quarter of fiscal year 2026–27. While all three enterprises delivered double-digit year-on-year revenue growth during the July–September 2026 period, investors on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) in Mumbai reacted in starkly contrasting ways depending on operating margin trajectories and bottom-line surprises.

Hyderabad-headquartered Nava Limited stole the spotlight after its consolidated net profit more than doubled, triggering an intraday rally of up to 9 percent before broader market profit-booking trimmed its gains. Conversely, hospitality operator Taj GVK Hotels & Resorts faced heavy selling pressure and slid over 4 percent after its quarterly profit declined despite a massive jump in top-line revenue, while pharmaceutical exporter Caplin Point Laboratories edged down more than 1 percent even after posting steady double-digit growth across revenue and earnings.

Nava Ltd Q2 FY27 Scorecard: Net Profit More Than Doubles to ₹315 Crore

Among Thursday’s earnings announcements, Nava Limited delivered the strongest operational beat, demonstrating substantial operating leverage across its diversified metals, energy, and mining businesses. According to regulatory disclosures filed for Q2 FY27, Nava’s consolidated net profit surged 144 percent year-on-year to reach ₹315 crore, more than doubling from the ₹129 crore reported in the corresponding quarter of the previous financial year.

Consolidated revenue from operations expanded at a brisk pace of 29.9 percent, climbing to ₹1,252.3 crore compared to ₹964 crore a year earlier.

Core operating profitability expanded even faster than top-line sales, underscoring disciplined cost efficiency and favorable realizations. Earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 51.3 percent year-on-year to ₹478 crore in the second quarter, up sharply from ₹316 crore in Q2 FY26.

Consequently, Nava’s consolidated EBITDA margin widened by 540 basis points to 38.1 percent from 32.7 percent in the year-ago period. Following the blockbuster release, the Nifty 500 constituent witnessed heightened trading volatility on the NSE and BSE. Buyers initially chased the counter up as much as 9 percent intraday, though persistent afternoon selling across broader mid-cap indices eventually pared the stock’s advance to under 5 percent.

Taj GVK Hotels Q2 Results: Strong 56% Revenue Surge Offset by Profit Dip

In the domestic hospitality space, Taj GVK Hotels & Resorts—a prominent joint venture between the Tata Group’s Indian Hotels Company Limited (IHCL) and the Hyderabad-based GVK Group—presented a mixed financial picture that prompted immediate caution among equity traders. During the second quarter of FY27, Taj GVK recorded an impressive 56.1 percent year-on-year jump in revenue from operations, which climbed to ₹167 crore compared to ₹107 crore in the same period last year, supported by healthy room occupancy and corporate travel demand across its luxury properties in Hyderabad, Chennai, Chandigarh, and Bengaluru.

However, brisk top-line expansion failed to translate into bottom-line growth. Taj GVK’s net profit declined 24.6 percent year-on-year to ₹21.1 crore in Q2 FY27, down from ₹28 crore in the corresponding quarter a year earlier. While operating profit (EBITDA) rose 47.3 percent to ₹49.2 crore from ₹33.4 crore in the prior-year period, the company’s EBITDA margin compressed by 170 basis points to 29.5 percent compared to 31.2 percent last year. Market analysts noted that rising operating expenses, higher depreciation or finance costs, and margin dilution overshadowed the strong revenue momentum, triggering a sell-off that pushed Taj GVK shares down by more than 4 percent during Thursday’s session.

Caplin Point Laboratories Q2 Performance: Steady Growth Fails to Lift Stock

Chennai-headquartered pharmaceutical manufacturer Caplin Point Laboratories delivered another quarter of consistent, predictable expansion across its core emerging market formulations and sterile injectables businesses, yet its shares succumbed to mild post-results profit-taking. For the quarter ended September 2026, Caplin Point’s consolidated net profit rose 15.3 percent year-on-year to ₹178 crore, up from ₹154.4 crore in the second quarter of fiscal year 2025–26.

Top-line momentum remained steady as revenue from operations grew 18 percent year-on-year to ₹630 crore compared to ₹534 crore in the year-ago period. Operating profit (EBITDA) mirrored revenue growth almost identically, advancing 18.1 percent to ₹223.4 crore against ₹189.2 crore a year earlier. Meanwhile, EBITDA margin held remarkably firm at 35.5 percent, edging up by a marginal 10 basis points from 35.4 percent in Q2 FY26. Despite maintaining industry-leading operating margins above 35 percent, shares of Caplin Point Laboratories slipped more than 1 percent following the announcement, reflecting routine consolidation after investors had largely priced in steady mid-teen earnings growth ahead of the release.

Key Takeaways for Dalal Street Investors Navigating Q2 Earnings

The divergent market reactions to Nava Limited, Taj GVK Hotels, and Caplin Point Laboratories highlight a defining theme of the Q2 FY27 earnings season across India’s financial hubs—from Mumbai and Ahmedabad to Hyderabad, Chennai, Bengaluru, and Lucknow. Institutional and retail investors are no longer rewarding top-line revenue expansion in isolation; instead, capital is rotating decisively toward companies capable of expanding operating margins and converting sales growth into superior bottom-line cash flows.

While Nava Limited’s 540-basis-point margin expansion and 144 percent profit surge earned immediate market applause despite broader index choppiness, Taj GVK’s 170-basis-point margin contraction drew swift valuation discipline, reminding market participants that earnings quality remains paramount in a selective equity environment.